课题基金 / 基金详情

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
管理和外展核心通过管理SPORE支持SPORE项目和调查人员 资源,质量控制,沟通和推广,包括促进SPORE之间的互动 组成部分和合作者,其他SPORES,患者和倡导者社区以及NCI。这 管理和支助是通过一系列监督委员会完成的, SPORE研究者、机构代表和外部人员的行政和科学会议 顾问。核心的具体职能包括: ·行政管理和协调所有与SPORE相关的研究 ·监督和管理财务资源 ·创建和准备文件和报告,以确保符合联邦法规, 报告要求 ·管理发展研究(试点项目)和职业发展计划 ·组织所有与乳腺癌SPORE活动相关的会议,研讨会和旅行 ·作为联络点,以所有VICC筹款活动集中在乳腺癌 ·支持和协调所有内部和外部合作 ·作为生物技术和制药公司的主要联系人 卡洛斯湖Arteaga,医学博士和Jane Kennedy,MSSW,将担任核心的联合董事。Arteaga报道 直接联系VICC主任Jennifer Pietenpol博士,并得到副主任的协助 (丹尼尔比彻姆,医学博士)和副主任基础科学(斯科特希伯特,博士)和癌症 流行病学,预防和控制(威廉·布洛博士)。Arteaga向Pietenpol博士提供建议, 方案指导和分配VICC资源用于乳腺癌研究。自2006年以来,简女士 Kennedy曾担任VICC患者与社区教育办公室的患者倡导经理 (OPACE)。肯尼迪女士的作用包括招募,培训和协调幸存者和照顾者, 促进和支持VICC的研究倡导计划,包括乳腺孢子。
英文摘要
The Administration & Outreach Core supports SPORE projects and investigators by managing SPORE resources, quality control, and communication and outreach, including fostering interaction among SPORE components and collaborators, other SPORES, the patient and advocate community, and the NCI. This management and support is accomplished through a series of oversight committees and organized administrative and scientific meetings of SPORE investigators, institutional representatives and external advisors. Specific functions of the Core include: • To administratively manage and coordinate all SPORE-related research • To monitor and manage financial resources • To create and prepare documents and reports to ensure compliance with federal regulations and reporting requirements • To administer the Developmental Research (pilot project) and Career Development Programs • To organize all meetings, seminars, and travel related to Breast Cancer SPORE activities • To serve as a point of contact to all VICC fundraising activities focused in breast cancer • To support and coordinate all internal and external collaborations • To serve as a main point of contact to biotechnology and pharmaceutical companies Carlos L. Arteaga, MD, and Jane Kennedy, MSSW, will serve as co-Directors of the Core. Arteaga reports directly to Jennifer Pietenpol, PhD, Director of VICC, and has input and assistance from the Deputy Director (Daniel Beauchamp, MD) and the Associate Directors for Basic Science (Scott Hiebert, PhD) and Cancer Epidemiology, Prevention & Control (William Blot, PhD). Arteaga provides advice to Dr. Pietenpol on programmatic directions and allocation of VICC resources for research in breast cancer. Since 2006, Ms. Jane Kennedy has served as Manager of Patient Advocacy in the VICC Office of Patient & Community Education (OPACE). Ms. Kennedy's role includes recruiting, training and coordinating the survivors and caregivers who contribute to and support the Research Advocacy Program of VICC, including the Breast SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
海外基金